Ameritas Advisory Services, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 59 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Advisory Services, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$64,579
-31.9%
44,232
-2.4%
0.01%
+60.0%
Q1 2023$94,856
+85.3%
45,3020.0%0.01%
+150.0%
Q4 2022$51,191
-30.8%
45,3020.0%0.00%
-50.0%
Q3 2022$74,000
+25.4%
45,3020.0%0.00%
+33.3%
Q2 2022$59,000
-16.9%
45,302
+2.4%
0.00%0.0%
Q1 2022$71,000
-22.8%
44,2320.0%0.00%0.0%
Q4 2021$92,00044,2320.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders